logo

For the Inventor, By the Inventor

Oxford, United Kingdom

Kevin Alan Myers

This inventor holds 14 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Oxford Biomedica (UK) Limited, Oxford Biomedica, Inc.. Active years: 2005-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Alan Myers. Retrieved from https://idiyas.com/inventor/kevin-alan-myers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 28.6

 

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 46(Granted Patents)


Location History:

  • Wantage, GB (2005 - 2010)
  • Oxon, GB (2006 - 2010)
  • Oxford, GB (2006 - 2011)

Company Filing History:

goldMedal13 out of 53 
 
Oxford Biomedica (UK) Limited
 patents
silverMedal1 out of 5 
 
Oxford Biomedica, Inc.
 patents

Years Active: 2005-2011

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 8084249 - Vector (2011-12-27),
2. 7718627 - Vector (2010-05-18),
3. 7666669 - Polypeptide (2010-02-23),
4. 7659383 - Feline 5T4 antigen (2010-02-09),
5. 7635687 - Vector system (2009-12-22),
6. 7615612 - Polypeptide (2009-11-10),
7. 7601698 - Polypeptide (2009-10-13),
8. 7531648 - Vector encoding an antibody that binds 5T4 antigen (2009-05-12),
9. 7514546 - Antibodies (2009-04-07),
10. 7402666 - Nucleotide encoding canine 5T4 antigen (2008-07-22),
11. 7276488 - Vector system (2007-10-02),
12. 7148035 - Polypeptide (2006-12-12),
13. 7074909 - Antibodies (2006-07-11),
14. 6852703 - Tumor targeted vector (2005-02-08),

Title: Kevin Alan Myers: Innovator in Tumor-Targeting Vectors

Introduction

Kevin Alan Myers is a distinguished inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of vectors that target tumors. With a total of 14 patents to his name, Myers has established himself as a key figure in innovative medical solutions.

Latest Patents

Among his latest patents, Myers has developed a vector comprising a nucleotide sequence of interest (NOI) that encodes a product of interest (POI). This vector is designed to recognize tumors, allowing for the targeted delivery of the NOI and/or the POI directly to the tumor site. This innovative approach has the potential to enhance the effectiveness of cancer treatments.

Career Highlights

Throughout his career, Myers has worked with notable companies, including Oxford Biomedica Limited and Oxford Biomedica, Inc. His work in these organizations has contributed to advancements in gene therapy and cancer treatment methodologies.

Collaborations

Myers has collaborated with esteemed colleagues such as Miles William Carroll and Christopher Robert Bebbington. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kevin Alan Myers is a prominent inventor whose work in tumor-targeting vectors has the potential to revolutionize cancer treatment. His contributions to biotechnology and his collaborations with other experts highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…